Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model

The ability of the osteoinductive protein and recombinant human bone morphogenetic protein-2, combined with polylactic glycolic acid porous microspheres and autologous blood clot to heal a large segmental defect was tested in a rabbit diaphyseal defect model. Two centimeter nonuniting defects were surgically created in the bilateral ulnae of 50 male New Zealand white rabbits. Each defect was then implanted with a pastelike polylactic glycolic acid/blood clot combination that was mixed with 5 different concentrations of recombinant human bone morphogenetic protein-2. The forearms were radiographically assessed on a biweekly schedule for 8 weeks. At 8 weeks, all animals were sacrificed and forearms radiographed. Radiographs were then scored by 3 independent observers for bone formation and union rates. United limbs were tested in torsion for mechanical strength using a Burstein torsion tester. All nonunited limbs were analyzed histologically as were 2 united limbs from each dosage group. Radiographic evaluation revealed that there was a dose dependent response in healing of the ulnar defect with a higher bone formation rate in the 2 higher dose limbs than in the lower dose limbs. Union was achieved in 100% of the highest dose limbs, whereas only 50% of the lowest dose limbs achieved bony union. No defects implanted with carrier alone achieved union. Biomechanical studies revealed significantly stiffer bone than age matched controls. Histologic analysis demonstrated normal bone formation with abundant normal appearing osteoid. These dose response data further support the role of recombinant human bone morphogenetic protein-2 as a potent morphogen in bone regeneration.

[1]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[2]  Musculoskeletal,et al.  Bone and Cartilage Allografts: Biology and Clinical Applications , 1991 .

[3]  J. Wozney,et al.  The bone morphogenetic protein family and osteogenesis , 1992, Molecular reproduction and development.

[4]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[5]  E. E. Johnson,et al.  Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. , 1992, Clinical orthopaedics and related research.

[6]  N Muthukumaran,et al.  Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Finerman,et al.  Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. , 1988, Clinical orthopaedics and related research.

[8]  M. Urist,et al.  Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. , 1988, Clinical orthopaedics and related research.

[9]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[10]  B. Summers,et al.  Donor site pain from the ilium. A complication of lumbar spine fusion. , 1989, The Journal of bone and joint surgery. British volume.

[11]  M. Urist,et al.  Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. , 1985, Clinical orthopaedics and related research.

[12]  A. Burstein,et al.  A standard test for laboratory animal bone. , 1971, Journal of biomechanics.

[13]  C J Damien,et al.  Bone graft and bone graft substitutes: a review of current technology and applications. , 1991, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[14]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[15]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[17]  Heppenstall Rb.  The present role of bone graft surgery in treating nonunion. , 1984 .

[18]  M. Chapman,et al.  Morbidity at bone graft donor sites. , 1989, Journal of orthopaedic trauma.

[19]  A. Burstein,et al.  The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. , 1984, The Journal of bone and joint surgery. American volume.

[20]  A. Lehninger,et al.  Influence of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth, on mineralization of cartilage and bone. , 1980, Biochemical and biophysical research communications.

[21]  M. Bostrom,et al.  Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2) , 1995 .

[22]  S. Cook,et al.  The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. , 1994, The Journal of bone and joint surgery. American volume.

[23]  J. Heckman,et al.  The use of bone morphogenetic protein in the treatment of non-union in a canine model. , 1991, The Journal of bone and joint surgery. American volume.

[24]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[25]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[26]  G. Balian,et al.  The use of demineralized bone matrix in the repair of segmental defects. Augmentation with extracted matrix proteins and a comparison with autologous grafts. , 1986, The Journal of bone and joint surgery. American volume.

[27]  M. Urist,et al.  23 Osteogenesis in the Interior of Intramuscular Implants of Decalcified Bone Matrix , 1965, Clinical orthopaedics and related research.

[28]  M M Panjabi,et al.  The four biomechanical stages of fracture repair. , 1977, The Journal of bone and joint surgery. American volume.

[29]  R. Heppenstall.  The present role of bone graft surgery in treating nonunion. , 1984, The Orthopedic clinics of North America.

[30]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  V. Rosen,et al.  Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. , 1986, The EMBO journal.

[32]  Y. Jin,et al.  Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions. , 1990, Clinical orthopaedics and related research.

[33]  T. Schmalzried,et al.  Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. , 1986, The Journal of bone and joint surgery. British volume.

[34]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[35]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.